The twelve hallmarks of aging

A scaffold for understanding why interventions work. Twelve interconnected biological processes — DNA damage, telomere shortening, mitochondrial dysfunction, cellular senescence, and others — drive the aging process. Every credible longevity intervention claims to target at least one of them. The framework is the most useful single map for evaluating whether something "anti-aging" is operating on real biology or just marketing.

The hallmarks-of-aging framework, introduced by López-Otín and colleagues in Cell in 2013 and substantially expanded in 2023, is the dominant biological framework for understanding the molecular and cellular processes that drive aging.^[1]^[2] The current version proposes twelve interconnected hallmarks, organised into three categories: primary (root causes), antagonistic (initially protective, eventually deleterious when sustained), and integrative (systemic consequences).

Why this framework matters

The hallmarks framework is the theoretical basis for nearly every "anti-aging" intervention — supplements, drugs, lifestyle protocols. Understanding them lets you evaluate whether a proposed intervention actually targets aging biology, or just markets itself that way.

To qualify as a hallmark, a process must:

Manifest naturally during physiological aging
Experimentally accelerate aging when exaggerated
Slow aging and extend healthspan when targeted

Primary hallmarks: root causes

1. Genomic instability

Accumulation of DNA damage from environmental toxins, ultraviolet (UV) radiation, and endogenous oxidative stress. As the cell's DNA-repair systems themselves become error-prone with age, somatic mutations accumulate, compromising cellular function and driving oncogenesis.^[3] The cells with the highest mutation burden are also the cells most likely to become senescent or transformed. Crucially, the damage doesn't stay local: DNA that leaks into the cytoplasm — from ruptured micronuclei or damaged mitochondria — is detected by the cGAS-STING sensor as if it were a virus, driving the chronic inflammation (inflammaging, #11) that turns a per-cell problem into a systemic one. See Genomic instability for the full picture.

Targeted by: an antioxidant-rich Mediterranean-pattern diet (Dietary patterns), reduced exposure to documented environmental toxins (Environmental toxins), sufficient sleep (the glymphatic and DNA-repair systems both peak during sleep), and exercise — with cohort data suggesting volumes above the standard activity guideline best slow biological-aging clocks.

2. Telomere attrition

Telomeres are protective nucleoprotein caps on chromosome ends. They progressively shorten with each cell division — the so-called "end-replication problem" — and, when critically short, trigger replicative senescence or apoptosis.^[4] Shorter telomeres correlate with cardiovascular disease, dementia, central obesity, and all-cause mortality in pooled cohort data. But the relationship is U-shaped, not linear: genetically longer telomeres causally raise cancer risk, so "longer is better" is false and consumer telomere tests are too noisy to act on. See Telomere attrition for the full picture.

Targeted by: regular cardiovascular exercise (consistently associated with longer telomeres in cohorts), chronic-stress reduction, adequate sleep, Mediterranean-pattern dietary intake. Pharmacological telomerase reactivation is a speculative target with substantial cancer-risk concerns.

3. Epigenetic alterations

Progressive degradation of the cellular "software" — DNA methylation patterns, histone modifications, chromatin organisation. Cells lose their precise molecular identities; tissues drift from their original transcriptional programs. The marks scramble in two directions at once — a global loss of silencing alongside over-silencing of specific protective genes — and, because they are reversible, this is the most intervenable primary hallmark. See Epigenetic alterations for the full picture.

Epigenetic clocks — Horvath, GrimAge, DunedinPACE, DamAge / AdaptAge — read these methylation patterns to estimate biological age, and they're now the most rigorous human biomarkers of aging.^[5]^[6]^[7]^[8]

Targeted by: structured exercise, time-restricted and intermittent fasting protocols, sustained caloric restriction (which slowed the DunedinPACE pace-of-aging clock in the randomized CALERIE trial), methyl-donor-adequate diet (folate, B12, choline), reductions in added-sugar intake (a recent NIMHD analysis tied added-sugar intake to dose-response acceleration of GrimAge2 and DunedinPACE in midlife women).^[9] Partial cellular reprogramming with Yamanaka factors is an experimental frontier with major safety concerns.

4. Loss of proteostasis

Failure of protein quality control — the molecular chaperone systems, autophagy, and the ubiquitin-proteasome pathway. Misfolded protein aggregates accumulate; the result includes Alzheimer's disease, Parkinson's disease, and systemic amyloidoses.

Targeted by: heat-shock activation via sauna, fasting-induced autophagy, polyphenol-rich dietary patterns, exercise, sleep — particularly the glymphatic clearance during deep sleep.

Antagonistic hallmarks: initially protective, eventually deleterious

5. Disabled macroautophagy (newly elevated in 2023)

Autophagy is the cell's protein-and-organelle recycling program. It slows with age, leaving cells burdened by damaged mitochondria, oxidised proteins, and aggregated cargo that no longer get cleared.^[10] The 2023 expansion of the framework promoted disabled autophagy to a hallmark in its own right because of its central role linking nutrient sensing, mitochondrial quality, and proteostasis. Its decline feeds neurodegeneration, heart failure, sarcopenia, and — via failed mitophagy and the NLRP3 inflammasome — inflammaging. See Disabled macroautophagy for the full picture.

Targeted by: caloric restriction and time-restricted eating (Fasting), endurance exercise, spermidine (a polyamine that induces autophagy and extends lifespan in animal models), and direct mTOR inhibition with rapamycin.

6. Deregulated nutrient sensing

The most heavily targeted hallmark across the entire field. The mTOR (anabolic) and AMPK / sirtuin (catabolic) signalling networks become miscalibrated; chronic mTOR activation from constant nutrient surplus drives growth while suppressing repair. The mechanism unifies metabolic flexibility, cellular senescence, autophagy, and mitochondrial biogenesis. The four fuel gauges — insulin/IGF-1, mTOR, AMPK, sirtuins — and the growth-versus-repair logic are laid out under Deregulated nutrient sensing; see also Protein and Metabolic flexibility for the dietary detail.

Targeted by:

Caloric restriction, fasting, time-restricted eating
Exercise (the most reliable AMPK activator)
Pharmacology: rapamycin (direct mTOR inhibitor)^[11]; metformin (AMPK activator with consistent observational signal in T2D); GLP-1 receptor agonists, the first drug class to measurably decelerate validated epigenetic clocks in human trials (see Ozempic-class drugs)
Reduced chronic insulin / IGF-1 stimulation through diet quality and body-composition optimisation

7. Mitochondrial dysfunction

Mitochondria accumulate mitochondrial-DNA mutations and structural damage. ATP production falls; reactive oxygen species (ROS) and leaked mitochondrial fragments trigger NLRP3-inflammasome and cGAS-STING signalling, fuelling inflammaging.^[12] Aged tissue accumulates oversized, dysfunctional "megamitochondria" that the cell can no longer isolate via fission and clear via mitophagy. The key practical principle is mitohormesis: brief, controlled mitochondrial stress (exercise, fasting, heat, cold) triggers adaptive renewal — which is why those levers work and high-dose antioxidants don't. See Mitochondrial dysfunction for the full picture.

Targeted by: aerobic exercise — particularly zone 2 training, the most potent stimulus for mitochondrial biogenesis via the AMPK → PGC-1α axis — plus high-intensity intervals (which preferentially drive mitochondrial quality, fusion, and mitophagy). Pharmacological adjuncts: urolithin A (a postbiotic mitophagy inducer with human-trial muscle-function data) and the NAD⁺ precursors nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR), where human longevity evidence is preliminary.

8. Cellular senescence

"Zombie cells" — irreversibly growth-arrested but metabolically active, secreting a continuous mix of inflammatory cytokines, chemokines, and matrix-degrading proteases known as the senescence-associated secretory phenotype (SASP). Useful in youth as a tumour-suppressive and wound-healing mechanism; deleterious when senescent cells accumulate in aged tissues.^[13] See Cellular senescence for the full picture.

Targeted by: exercise and dietary patterns (modest effect via reduced inflammatory drive), fasting (some senolytic signal in animal models). Senolytics — drugs that selectively kill senescent cells, most notably dasatinib + quercetin (Mayo Clinic, Kirkland and Tchkonia) and fisetin — show striking pre-clinical efficacy and are now in human trials for specific indications. Not yet a routine intervention.

Integrative hallmarks: systemic consequences

9. Stem-cell exhaustion

Progressive depletion or functional decline of tissue-regenerating stem-cell pools — including muscle satellite cells, intestinal crypt stem cells, hematopoietic stem cells, and neural progenitors. Tissues progressively lose the capacity to regenerate or to replace damaged cells.

Targeted by: exercise (preserves muscle satellite-cell pools and improves their responsiveness), hormonal sufficiency (menopause and andropause both accelerate stem-cell decline), nutrient adequacy. Stem-cell-injection therapies remain largely experimental for most age-related conditions.

10. Altered intercellular communication

The hormonal, immune, neuroendocrine, and paracrine signalling networks that coordinate tissues break down with age. Cells stop hearing each other accurately — senescent-cell secretions add inflammatory noise, the physical channels between cells (gap junctions, the extracellular matrix) degrade, and the blood itself accumulates pro-aging factors that parabiosis experiments show actively drive decline. See Altered intercellular communication for the full picture.

Targeted by: hormonal optimisation when indicated — menopausal hormone therapy initiated within the critical window, testosterone therapy in symptomatic hypogonadism, thyroid management; reduced systemic inflammation; and — perhaps surprisingly — social engagement, since social signals modulate the immune-endocrine system in measurable ways (Purpose).

11. Chronic inflammation ("inflammaging") (added 2023)

A sterile, low-grade, persistent inflammatory state pervades aging tissues — fuelled by senescent cells, leaked mitochondrial DNA, gut-barrier breakdown, and persistent low-level antigen exposure. Inflammaging directly drives atherosclerosis, osteoarthritis, insulin resistance, and neurodegeneration.^[14] See Chronic inflammation for the full picture.

Targeted by: Mediterranean-pattern diet (Dietary patterns), regular exercise, adequate and consistent sleep, reduced visceral adiposity, EPA/DHA omega-3 intake, and periodic fasting.

12. Dysbiosis (added 2023)

An age-related shift in the gut microbiome — loss of diversity, overgrowth of pathogenic taxa, depletion of butyrate-producing species like Faecalibacterium prausnitzii and Akkermansia muciniphila. The resulting increased intestinal permeability allows endotoxin leakage, exacerbating inflammaging through the gut-immune axis. Centenarian guts suggest the goal is functional resilience (sustained SCFA production, pathobiont suppression) rather than a fixed "young" species list. See Dysbiosis for the full picture.

Targeted by: high-fibre diet, fermented foods (the food-matrix effect is more important than live colony counts), prebiotic vegetables, judicious use of antibiotics, and possibly targeted probiotic strains for specific conditions.

How interventions map to hallmarks

Intervention	Hallmarks targeted
Mediterranean diet	Inflammation, dysbiosis, epigenetic, oxidative damage
Exercise (aerobic)	Mitochondrial dysfunction, telomere attrition, inflammation, autophagy
Resistance training	Stem cell exhaustion (muscle), intercellular communication
Fasting / TRE	Nutrient sensing, autophagy, epigenetic, mitochondrial — mechanism robust; epigenetic-clock slowing shown in the CALERIE RCT, but no human lifespan/mortality trial
Sleep adequacy	Genomic instability (DNA repair), proteostasis (glymphatic), inflammation
Mediterranean / MIND diet	Inflammation, nutrient sensing, dysbiosis, oxidative damage
Sauna	Proteostasis (HSPs), inflammation, cardiovascular
Cold exposure	Mitochondrial (modest), antioxidant defenses — mechanistic; no human longevity outcome data
Rapamycin	Nutrient sensing (mTOR), autophagy
Metformin	Nutrient sensing (AMPK), inflammation
GLP-1 RAs (semaglutide, tirzepatide)	Nutrient sensing, autophagy, mitochondrial, senescence, inflammaging — first drug class to measurably decelerate validated epigenetic clocks in a human RCT
Senolytics	Cellular senescence
NAD+ precursors	Mitochondrial (mechanistically; limited human evidence)

Causality-enriched epigenetic clocks: DamAge and AdaptAge

A 2023 Nature Aging paper introduced two new metrics:

DamAge — tracks methylation changes causally linked to accelerating aging (irreversible damage)
AdaptAge — tracks protective methylation changes that retard aging (compensatory adaptation)

This framework reframes aging not as passive decay but as a dynamic struggle between damage and adaptive resilience. Interventions should be evaluated not just on halting damage, but on upregulating adaptive resilience.

This may explain why some interventions (exercise, dietary patterns) work despite modest individual effects on traditional biomarkers — they upregulate adaptation.

A practical biological-aging proxy: heart rate variability

Epigenetic clocks are powerful but require lab work and bring their own measurement caveats. A more accessible — and continuously trackable — proxy is heart rate variability (HRV), the millisecond fluctuation between heartbeats. HRV correlates with biological aging via the autonomic nervous system, the vagal anti-inflammatory pathway, and downstream cardiometabolic resilience. A 2025 machine-learning study built an "Autonomic Age" from HRV-derived features and found high-risk cardiovascular profiles ran ~10 years older biologically than calendar age, while optimal profiles ran ~2 years younger. See Heart rate variability for the full picture, including what consumer wearables actually measure accurately.

What the framework does and doesn't tell you

What it tells you:

The biology of aging is mechanistically complex, not random decay.
Multiple interventions target multiple hallmarks simultaneously — explaining why pattern-based approaches (Mediterranean diet, exercise) outperform single-molecule interventions.
Pharmacological interventions are real but not ready for healthy adults absent specific indications.

What it doesn't tell you:

That any specific supplement or drug currently extends human life.
That the hormetic lifestyle levers do more than engage the biology. The mechanisms are real, but fasting and cold exposure have no human longevity-outcome trials — fasting also carries safety caveats (an observational cardiovascular-mortality signal for very short eating windows; a refeeding-proliferation concern), and cold's popular metabolic and anti-inflammatory claims largely don't survive scrutiny.
That there's a single "master switch" for aging.
That the field has solved aging.

The honest message: the framework is sophisticated; the interventions matched to it (in healthy adults, for hard outcomes) remain modest at best.